Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 88, Issue 16, 1991, Pages 7238-7241

  Ferre, Sergi ^a,b   Von Euler, Gabriel ^a   Johansson, Björn ^a   Fredholm, Bertil B ^a   Fuxe, Kjell ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b CSIC   (Spain)

Author keywords

2 p (2 carboxyethyl)phenethylamino 5 N ethylcarboxainidoadenosine; GTP; N ropylnorapomorphine; Raclopride; Receptor receptor interactions

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2 RECEPTOR; DOPAMINE 2 RECEPTOR; GUANOSINE TRIPHOSPHATE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CORPUS STRIATUM; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOSINE; ANIMAL; APOMORPHINE; BINDING, COMPETITIVE; CELL MEMBRANE; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; KINETICS; MALE; PHENETHYLAMINES; PHENYLISOPROPYLADENOSINE; RACLOPRIDE; RATS; RATS, INBRED STRAINS; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D2; RECEPTORS, PURINERGIC; SALICYLAMIDES; SCH-23390; SUPPORT, NON-U.S. GOV'T; THEOPHYLLINE;

ANIMALIA;

EID: 0025768754     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.88.16.7238     Document Type: Article

References (44)

1. Fredholm, B. B. & Hedqvist, P. (1980) Biochem. Pharmacol. 29, 1635-1643.
2. Durmiddie, T. V. (1985) Int. Rev. Neurobiol. 27, 63-139.
3. Snyder, S. H. (1985) Annu. Rev. Neurosci. 8, 103-124.
4. Daly, J. W., Butts-Lamb, P. & Padgett, W. (1983) Cell. Mol. Neurobiol. 1, 69-80.
5. Bruns, R. F., Ku, G. H. & Pugsley, T. A. (1986) Mol. Pharmacol. 29, 331-346.
6. van Calker, D., Möller, M. & Hamprecht, B. (1979) J. Neurochem. 33, 999-1005.
7. Premont, J., Perez, M., Blanc, G., Tassin, J.-P., Thierry, H.-M. Hervé, D. & Bockaert, J. (1979) Mol. Pharmacol. 16, 790-804.
8. Onali, P., Olianas, M. C. & Bunse, B. (1988) Brain Res. 456, 302-309.
9. Booth, R. G. & Baldessarini, R. J. (1990) Eur. J. Pharmacol. 185, 217-221.
10. Jarvis, M. F. & Williams, M. (1989) Eur. J. Pharmacol. 168, 243-246.
11. Parkinson, F. E. & Fredholm, B. B. (1990) Naunyn-Schmiedeberg's Arch. Pharmacol. 342, 85-89.
12. Alexander, S. P. & Reddington, M. (1989) Neuroscience 28, 645-651.
13. Boyson, S. J., McGonigle, P. & Scatton, P. B. (1986) J. Neurosci. 6, 3177-3182.
14. Maenhaut, C., Van Sande, J., Libert, F., Abramowicz, M., Parmentier, M., Vanderhaegen, J.-J., Dumont, J. E., Vassart, G. & Schiffman, S. (1990) Biochem. Biophys. Res. Commun. 173, 1169-1178.
15. Schiffmann, S. N., Libert, F., Vassart, G., Dumont, J. E. & Vanderhaegen, J.-J. (1990) Brain Res. 519, 333-337.
16. Waldeck, B. (1973) J. Neural Trans. 34, 61-72.
17. Snyder, S. H., Katims, J. J., Annau, Z., Bruns, R. F. & Daly, J. W. (1981) Proc. Natl. Acad. Sci. USA 78, 3260-3264.
18. Fuxe, K. & Ungerstedt, U. (1974) Med. Biol. 52, 48-54.
19. Green, R. D., Proudfit, H. K. & Yeung, S.-M. H. (1982) Science 218, 58-61.
20. Fredholm, B. B., Fuxe, K. & Agnati, L. (1976) Eur. J. Pharmacol. 38, 31-38.
21. Durcan, M. J. & Morgan, P. F. (1989) Eur. J. Pharmacol. 168, 285-290.
22. Heffner, T. G., Wiley, J. N., Williams, A. E., Bruns, R. F., Coughenour, L. L. & Downs, D. A. (1989) Psychopharmacology 98, 31-37.
23. Seeman, P. (1987) Synapse 1, 133-152.
24. Ferré, S., Herrera-Marschitz, M., Grabowska-Andén, M., Ungerstedt, U., Casas, M. & Andén, N.-E. (1991) Eur. J. Pharmacol. 192, 25-30.
25. Ferré, S., Herrera-Marschitz, M., Grabowska-Andén, M., Casas, M., Ungerstedt, U. & Andén, N.-E. (1991) Eur. J. Pharmacol. 192, 31-37.
26. Onali, P., Olianas, M. C. & Gessa, G. L. (1985) Mol. Pharmacol. 28, 138-145.
27. Fuxe, K., Celani, M. F., Martire, M., Zini, I., Zoli, M. & Agnati, L. F. (1984) Eur. J. Pharmacol. 100, 127-130.
28. Seeman, P., Niznik, H. B., Guan, H.-C., Booth, G. & Ulpian, C. (1989) Proc. Natl. Acad. Sci. USA 86, 10156-10160.
29. Agnati, L. F., Fuxe, K., Benfenati, F. & Battistini, N. (1983) Acta Physiol. Scand. 119, 459-461.
30. von Euler, G., Fuxe, K., Benfenati, F., Hansson, T., Agnati, L. F. & Gustafsson, J.-Å. (1989) Acta Physiol. Scand. 135, 443-448.
31. von Euler, G., van der Ploeg, I., Fredholm, B. B. & Fuxe, K. (1991) J. Neurochem. 56, 178-183.
32. Agnati, L. F., Celani, M. F. & Fuxe, K. (1983) Acta Physiol. Scand. 118, 79-81.
33. Hutchison, A. J., Webb, R. L., Oei, H. H., Ghai, G. R., Zimmerman, M. B. & Williams, M. (1989) J. Pharmacol. Exp. Ther. 251, 47-55.
34. Jarvis, M. F., Schulz, R., Hutchison, A. J., Hoi Do, U., Sills, M. A. & Williams, M. (1989) J. Pharmacol. Exp. Ther. 251, 888-893.
35. Lupica, C. R., Cass, W. A., Zahniser, N. R. & Dunwiddie, V. (1990) J. Pharmacol. Exp. Ther. 252, 1134-1141.
36. Köhler, C., Hall, H., Ögren, S.-O. & Gawell, L. (1985) Biochem. Pharmacol. 34, 2251-2259.
37. Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. (1951) J. Biol. Chem. 193, 265-275.
38. Hyttel, J. (1983) Eur. J. Pharmacol. 91, 153-154.
39. Munson, P. J. & Rodbard, D. (1980) Anal. Biochem. 107, 220-239.
40. Snedecor, G. W. & Cochran, W. G. (1980) in Statistical Methods (Iowa State Univ., Ames, 1A), pp. 291-292.
41. Zahniser, N. R. & Molinoff, P. B. (1978) Nature (London) 275, 453-455.
42. Creese, I., Sibley, D. R., Hamblin, M. W. & Leff, S. E. (1983) Annu. Rev. Neurosci. 6, 43-71.
43. von Euler, G., Meister, B., Hökfelt, T., Eneroth P. & Fuxe, K. (1990) Brain Res. 531, 253-262.
44. von Euler, G. (1991) Brain Res., in press.